世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Biofilms Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product ( Debridement Equipment, Gauzes & Dressings, Gels, Ointments & Sprays Grafts & Matrices, Wipes, Pads & Lavage Solutions), By Wound Type (Burns & Open Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Traumatic & Surgical Wounds, Venous Leg Ulcers), By End user (Home Care Settings, Hospitals, ASCs & Wound Care Centers), By Region & Competition,  2020-2030F

Biofilms Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product ( Debridement Equipment, Gauzes & Dressings, Gels, Ointments & Sprays Grafts & Matrices, Wipes, Pads & Lavage Solutions), By Wound Type (Burns & Open Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Traumatic & Surgical Wounds, Venous Leg Ulcers), By End user (Home Care Settings, Hospitals, ASCs & Wound Care Centers), By Region & Competition, 2020-2030F


Global Biofilms Treatment Market was valued at USD 1.75 billion in 2024 and is anticipated to project significant growth in the forecast period with a CAGR of 5.47% through 2030. The global biofilm... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
TechSci Research
テックサイリサーチ
2025年3月28日 US$4,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
PDF:2営業日程度 187 英語

 

Summary

Global Biofilms Treatment Market was valued at USD 1.75 billion in 2024 and is anticipated to project significant growth in the forecast period with a CAGR of 5.47% through 2030. The global biofilms treatment market has witnessed significant growth and innovation in recent years, offering a promising frontier in healthcare. Biofilms are complex communities of microorganisms, including bacteria, fungi, and other microorganisms, that adhere to surfaces and form protective matrices. These biofilms are found in various industries and medical settings, causing significant challenges in healthcare, environmental management, and industrial processes. As our understanding of biofilms has advanced, so too has our ability to develop effective treatments to combat them. According to WHO (2023), antimicrobial resistance (AMR) is a major global public health and development threat. In 2019, bacterial AMR caused 1.27 million deaths and contributed to 4.95 million. Misuse and overuse of antimicrobials in humans, animals, and plants drive resistance. AMR disproportionately affects low- and middle-income countries, worsening poverty and inequality worldwide.
Biofilms are ubiquitous, existing in diverse environments such as water distribution systems, industrial pipelines, and medical devices. In healthcare, biofilm-related infections pose a severe threat, as they are resistant to traditional antibiotics and immune system responses. These infections can lead to chronic illnesses, increased healthcare costs, and even mortality. Therefore, the development of effective biofilm treatment strategies has become a top priority in the medical and pharmaceutical industries.
Increased awareness about the challenges posed by biofilms has driven demand for effective treatment options. Healthcare professionals and patients alike are recognizing the need for specialized biofilm treatments. The convergence of biotechnology, nanotechnology, and microbiology has facilitated the development of innovative treatment solutions. These advancements allow for targeted approaches to disrupt biofilm formation and enhance treatment efficacy. As global healthcare expenditure continues to rise, there is a growing willingness to invest in advanced biofilm treatment solutions. Governments and private sector players are allocating resources to support research and development efforts in this field. The alarming rise in antimicrobial resistance has accentuated the need for alternative treatment strategies. Biofilm-associated infections are notoriously resistant to antibiotics, making the development of biofilm-specific therapies crucial. Biofilm treatments are not limited to healthcare settings. They are also crucial in industries such as food processing, water management, and oil and gas. The versatility of biofilm treatments extends their market potential.
Key Market Drivers
Increasing Healthcare-Associated Infections (HAIs) is Driving the Global Biofilms Treatment Market
Healthcare-Associated Infections (HAIs) have been a persistent challenge in the medical field, causing significant morbidity and mortality worldwide. These infections are a consequence of bacteria forming biofilms on various medical devices, surfaces, and tissues, making them difficult to eradicate. As HAIs continue to rise, the demand for effective biofilm treatment solutions has fueled the growth of the Global Biofilms Treatment Market. Biofilms are complex, structured communities of microorganisms, primarily bacteria, that adhere to surfaces and produce a protective matrix of extracellular polymeric substances (EPS). These biofilms can be found in various healthcare settings, such as catheters, prosthetic devices, wound beds, and even on medical equipment. Biofilms play a critical role in HAIs as they enable bacteria to resist antibiotics, disinfectants, and host immune responses.
Key Market Challenges
Limited Understanding of Biofilm Biology
One of the primary challenges in biofilm treatment is the limited understanding of biofilm biology. Biofilms are highly heterogeneous and adaptive structures, making them difficult to study and target effectively. The complexity of biofilm formation, composition, and behavior varies greatly depending on the type of microorganisms involved, the host environment, and other factors. This variability makes it challenging to develop universal treatment approaches that can address all biofilm-related infections.
Key Market Trends
Technological Advancements
In recent years, the global biofilms treatment market has witnessed significant growth, thanks to the expanding technological advancements in the field. Biofilms, which are complex communities of microorganisms adhering to surfaces and encased in a protective matrix, have been a longstanding challenge in various industries, including healthcare, food processing, and water treatment. As our understanding of biofilms has deepened and innovative technologies have emerged, the global market for biofilms treatment has been on the rise.
Nanotechnology has played a pivotal role in biofilms treatment. Nanomaterials and nanoparticles have shown promising potential in disrupting biofilm formation and eradicating existing biofilms. These tiny structures can penetrate the protective matrix of biofilms, making them effective in various applications, including medical devices, wound care, and water treatment. Innovations in antimicrobial coatings have been instrumental in preventing biofilm formation on surfaces. These coatings release controlled doses of antimicrobial agents, inhibiting the growth of biofilms and reducing the risk of infections. They find applications in healthcare, food processing, and the construction industry. Early detection of biofilms is crucial for effective treatment. Advanced detection methods, such as biosensors and imaging techniques, have emerged. These technologies enable real-time monitoring and assessment of biofilm development, allowing for timely intervention. Researchers have developed novel strategies to disrupt biofilms, including using enzymes, bacteriophages, and quorum-sensing inhibitors. These approaches target the biofilm structure and the signalling mechanisms that enable microorganisms to coordinate their activities within the biofilm. Approaches: Biotechnology and genomics have enabled a better understanding of the biology of biofilms. By deciphering the genetic makeup of biofilm-forming microorganisms, researchers can develop targeted therapies and interventions, leading to more effective treatments.
Key Market Players
• Smith+Nephew healthcare private limited
• ConvaTec Group plc
• Zimmer Biomet Holdings, Inc.
• Mölnlycke Healthcare AB
• Organogenesis Inc.
• Integra LifeSciences Holdings Corp
• B. Braun Melsungen AG
• PAUL HARTMANN AG
• Medline Industries Inc.
• Welcare Industries S.p.A.
Report Scope:
In this report, the Global Biofilms Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Biofilms Treatment Market, By Product:
o Debridement Equipment
o Gauzes & Dressings
o Gels
o Ointments & Sprays Grafts & Matrices
o Wipes
o Pads & Lavage Solutions
• Biofilms Treatment Market, By Wound Type:
o Burns & Open Wounds
o Diabetic Foot Ulcers
o Pressure Ulcers
o Traumatic & Surgical Wounds
o Venous Leg Ulcers
• Biofilms Treatment Market, By End user:
o Home Care Settings
o Hospitals
o ASCs & Wound Care Centres
• Biofilms Treatment Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Biofilms Treatment Market.
Available Customizations:
Global Biofilms Treatment market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).


ページTOPに戻る


Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Biofilms Treatment Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Debridement Equipment, Gauzes & Dressings, Gels, Ointments & Sprays Grafts & Matrices, Wipes, Pads & Lavage Solutions)
5.2.2. By Wound Type (Burns & Open Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Traumatic & Surgical Wounds, Venous Leg Ulcers)
5.2.3. By End user (Home Care Settings, Hospitals, ASCs & Wound Care Centres)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Biofilms Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Wound Type
6.2.3. By End user
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Biofilms Treatment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Wound Type
6.3.1.2.3. By End user
6.3.2. Canada Biofilms Treatment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Wound Type
6.3.2.2.3. By End user
6.3.3. Mexico Biofilms Treatment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Wound Type
6.3.3.2.3. By End user
7. Europe Biofilms Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Wound Type
7.2.3. By End user
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Biofilms Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Wound Type
7.3.1.2.3. By End user
7.3.2. United Kingdom Biofilms Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Wound Type
7.3.2.2.3. By End user
7.3.3. Italy Biofilms Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Wound Type
7.3.3.2.3. By End user
7.3.4. France Biofilms Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Wound Type
7.3.4.2.3. By End user
7.3.5. Spain Biofilms Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Wound Type
7.3.5.2.3. By End user
8. Asia-Pacific Biofilms Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Wound Type
8.2.3. By End user
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Biofilms Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Wound Type
8.3.1.2.3. By End user
8.3.2. India Biofilms Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Wound Type
8.3.2.2.3. By End user
8.3.3. Japan Biofilms Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Wound Type
8.3.3.2.3. By End user
8.3.4. South Korea Biofilms Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Wound Type
8.3.4.2.3. By End user
8.3.5. Australia Biofilms Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Wound Type
8.3.5.2.3. By End user
9. South America Biofilms Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Wound Type
9.2.3. By End user
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Biofilms Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Wound Type
9.3.1.2.3. By End user
9.3.2. Argentina Biofilms Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Wound Type
9.3.2.2.3. By End user
9.3.3. Colombia Biofilms Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Wound Type
9.3.3.2.3. By End user
10. Middle East and Africa Biofilms Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Wound Type
10.2.3. By End user
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Biofilms Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Wound Type
10.3.1.2.3. By End user
10.3.2. Saudi Arabia Biofilms Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Wound Type
10.3.2.2.3. By End user
10.3.3. UAE Biofilms Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Wound Type
10.3.3.2.3. By End user
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. Smith+Nephew healthcare private Limited.
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. ConvaTec Group plc
14.3. Zimmer Biomet Holdings, Inc.
14.4. Mölnlycke Healthcare AB
14.5. Organogenesis Inc.
14.6. Integra LifeSciences Holdings Corp
14.7. B. Braun Melsungen AG
14.8. PAUL HARTMANN AG
14.9. Medline Industries Inc.
14.10. Welcare Industries S.p.A
15. Strategic Recommendations
16. About Us & Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

TechSci Research社のヘルスケア分野での最新刊レポート

本レポートと同じKEY WORD(industry)の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/04/08 10:26

148.77 円

163.31 円

192.60 円

ページTOPに戻る